From February 6, 2022 to March 31, 2022, the company has repurchased 680,000 shares, representing 0.21% for CNY 49.85 million. With this, the company has completed the repurchase of 680,000 shares, representing 0.21% for CNY 49.85 million under the buyback announced on February 7, 2022.
Qingdao Haier Biomedical Co.,Ltd
Equities
688139
CNE100003P25
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
39.48 CNY | +1.78% | +3.08% | -2.57% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.57% | 1.72B | |
+7.77% | 218B | |
+10.16% | 189B | |
+26.21% | 151B | |
+32.78% | 113B | |
+1.98% | 64.02B | |
+14.48% | 52.6B | |
+2.92% | 49.85B | |
-6.60% | 37.89B | |
-1.07% | 34.92B |
- Stock Market
- Equities
- 688139 Stock
- News Qingdao Haier Biomedical Co.,Ltd
- Tranche Update on Qingdao Haier Biomedical Co., Ltd's Equity Buyback Plan announced on February 7, 2022.